Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study.

Kristian Reich April W Armstrong Peter Foley Michael Song Megan Miller Y K Shen Yin You Chenglong Han Kenneth B Gordon

Published in: American journal of clinical dermatology (2021)

NCT02207244.

Keyphrases